Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

528 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial.
Smit EF, Felip E, Uprety D, Nagasaka M, Nakagawa K, Paz-Ares Rodríguez L, Pacheco JM, Li BT, Planchard D, Baik C, Goto Y, Murakami H, Saltos A, Pereira K, Taguchi A, Cheng Y, Yan Q, Feng W, Tsuchihashi Z, Jänne PA. Smit EF, et al. Among authors: pereira k. Lancet Oncol. 2024 Apr;25(4):439-454. doi: 10.1016/S1470-2045(24)00064-0. Lancet Oncol. 2024. PMID: 38547891 Clinical Trial.
Trastuzumab Deruxtecan in Patients With HER2-Mutant Metastatic Non-Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial.
Goto K, Goto Y, Kubo T, Ninomiya K, Kim SW, Planchard D, Ahn MJ, Smit EF, de Langen AJ, Pérol M, Pons-Tostivint E, Novello S, Hayashi H, Shimizu J, Kim DW, Kuo CH, Yang JC, Pereira K, Cheng FC, Taguchi A, Cheng Y, Feng W, Tsuchihashi Z, Jänne PA. Goto K, et al. Among authors: pereira k. J Clin Oncol. 2023 Nov 1;41(31):4852-4863. doi: 10.1200/JCO.23.01361. Epub 2023 Sep 11. J Clin Oncol. 2023. PMID: 37694347 Free PMC article. Clinical Trial.
Analytical and Clinical Validation of the Oncomine Dx Target Test to Assess HER2 Mutation Status in Tumor Tissue Samples From Patients With Non-Small Cell Lung Cancer Treated With Trastuzumab Deruxtecan in the DESTINY-Lung01 and DESTINY-Lung02 Studies.
Qi Z, Ha T, Feng W, Karnoub M, Pereira K, Shiga R, Smit EF, Goto Y, De Langen AJ, Goto K, Velasco Roth AM, Khambata-Ford S. Qi Z, et al. Among authors: pereira k. Arch Pathol Lab Med. 2024 Sep 20. doi: 10.5858/arpa.2024-0014-OA. Online ahead of print. Arch Pathol Lab Med. 2024. PMID: 39299708 Free article.
Blood Pressure Control and Clinical Outcomes After Renal Denervation Through Irrigated Catheter Radiofrequency Ablation in Patients with Resistant Hypertension: A Case Series with Up to 10 Years of Follow-Up.
do Carmo LV, Pereira KD, Goulart MA, Laurinavicius AG, Souza J, Junior OP, Armaganijan L, Staico R, Amodeo C, Abizaid A, Cesena FY, Sousa MG, Consolim-Colombo F. do Carmo LV, et al. Among authors: pereira kd. High Blood Press Cardiovasc Prev. 2024 Nov 18. doi: 10.1007/s40292-024-00685-7. Online ahead of print. High Blood Press Cardiovasc Prev. 2024. PMID: 39557771
Reply to the Comment on "Efficacy of N-Methyl-D-Aspartate (NMDA) Receptor Antagonists in Treating Traumatic Brain Injury-Induced Brain Edema: A Systematic Review and Meta-Analysis of Animal Studies".
Ribeiro FCP, de Oliveira NV, Coral GR, de Assis César AR, Gonçalves MWA, Egal ESA, Pereira KF. Ribeiro FCP, et al. Among authors: pereira kf. Neurocrit Care. 2024 Nov 12. doi: 10.1007/s12028-024-02167-z. Online ahead of print. Neurocrit Care. 2024. PMID: 39528782 No abstract available.
Impact of point-of-care birth test-and-treat on clinical outcomes among infants with HIV: A cluster randomized trial in Mozambique and Tanzania.
Jani IV, Sabi I, Elsbernd K, Meggi B, Mahumane A, Lwilla AF, Pereira K, Boniface S, Edom R, Lequechane J, Chale F, Chiwerengo N, Ntinginya NE, Mudenyanga C, Mueller M, Rauscher M, Hoelscher M, Taveira N, Buck WC, Kroidl A; LIFE study consortium. Jani IV, et al. Among authors: pereira k. Clin Infect Dis. 2024 Nov 8:ciae530. doi: 10.1093/cid/ciae530. Online ahead of print. Clin Infect Dis. 2024. PMID: 39514367
Rationale and Design of the DEFIANCE Study: A Randomized Controlled Trial of Mechanical Thrombectomy Versus Anticoagulation Alone for Iliofemoral Deep Vein Thrombosis.
Abramowitz SD, Marko X, D'Souza D, Noor S, Pereira K, Silver MJ, Rosenberg SP, Markovitz CD, Tu T, Weinberg I, Black S. Abramowitz SD, et al. Among authors: pereira k. Am Heart J. 2024 Nov 2:S0002-8703(24)00278-3. doi: 10.1016/j.ahj.2024.10.016. Online ahead of print. Am Heart J. 2024. PMID: 39491572 Free article.
Large-bore Mechanical Thrombectomy Versus Catheter-directed Thrombolysis in the Management of Intermediate-risk Pulmonary Embolism: Primary Results of the PEERLESS Randomized Controlled Trial.
Jaber WA, Gonsalves CF, Stortecky S, Horr S, Pappas O, Gandhi RT, Pereira K, Giri J, Khandhar SJ, Ammar KA, Lasorda DM, Stegman B, Busch L, Dexter Ii DJ, Azene EM, Daga N, Elmasri F, Kunavarapu CR, Rea ME, Rossi JS, Campbell J, Lindquist J, Raskin A, Smith JC, Tamlyn TM, Hernandez GA, Rali P, Schmidt TR, Bruckel JT, Camacho JC, Li J, Selim S, Toma C, Basra SS, Bergmark BA, Khalsa B, Zlotnick DM, Castle J, O'Connor DJ, Gibson CM; PEERLESS Committees and Investigators. Jaber WA, et al. Among authors: pereira k. Circulation. 2024 Oct 29. doi: 10.1161/CIRCULATIONAHA.124.072364. Online ahead of print. Circulation. 2024. PMID: 39470698 Free article.
528 results